Home › Funds › DRIEHAUS CAPITAL MANAGEMENT LLC › APGE
DRIEHAUS CAPITAL MANAGEMENT LLC position in APGE
APOGEE THERAPEUTICS INC
DRIEHAUS CAPITAL MANAGEMENT LLC reported holding 1,740,101 shares of APGE (APOGEE THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$231.0M, representing 1.34% of its reported portfolio and ranking #8 among its reported holdings. DRIEHAUS CAPITAL MANAGEMENT LLC has disclosed APGE holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How DRIEHAUS CAPITAL MANAGEMENT LLC's APGE position evolved
DRIEHAUS CAPITAL MANAGEMENT LLC first disclosed a stake in APGE in Q3 2023 at 1,339,275 shares (US$28.5M). The position peaked in Q2 2026 at 1,740,101 shares, worth US$231.0M. Across 12 filings, DRIEHAUS CAPITAL MANAGEMENT LLC increased the stake 5 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,740,101 shares valued at US$231.0M — a reduction of -180,699 shares quarter over quarter.. Notable position changes include a 55% increase in Q1 2024.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 1.34M | $28.53M | New |
| Q4 2023 | 1.33M | $37.13M | Reduce |
| Q1 2024 | 2.06M | $137.14M | Add |
| Q2 2024 | 2.12M | $83.34M | Add |
| Q3 2024 | 2.53M | $148.82M | Add |
| Q4 2024 | 2.61M | $118.02M | Add |
| Q1 2025 | 2.34M | $87.41M | Reduce |
| Q2 2025 | 2.31M | $100.36M | Reduce |
| Q3 2025 | 2.16M | $85.76M | Reduce |
| Q4 2025 | 2.18M | $164.83M | Add |
| Q1 2026 | 1.92M | $161.67M | Reduce |
| Q2 2026 | 1.74M | $230.96M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About APGE and 13F data
APGE (APOGEE THERAPEUTICS INC) is a company whose sector is not yet classified in our data. 59 other funds we track also report a position in APGE — the largest reported positions include Venrock Adviser, LLC (US$1.13B), HBK INVESTMENTS L P (US$378.3M), GLAZER CAPITAL, LLC (US$217.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding APGE
- Venrock Adviser, LLC 8.49M sh · $1.13B · Q2 2026
- HBK INVESTMENTS L P 2.85M sh · $378.28M · Q2 2026
- GLAZER CAPITAL, LLC 1.64M sh · $217.82M · Q2 2026
- Paradigm Biocapital Advisors LP 1.58M sh · $209.23M · Q2 2026
- Pentwater Capital Management LP 1.43M sh · $189.14M · Q2 2026
- PERCEPTIVE ADVISORS LLC 1.31M sh · $173.63M · Q2 2026
- Affinity Asset Advisors, LLC 987.00K sh · $131.00M · Q2 2026
- First Light Asset Management, LLC 930.29K sh · $123.48M · Q2 2026
- Kryger Capital LLC 742.55K sh · $98.56M · Q2 2026
- First Trust Capital Management L.P. 625.18K sh · $82.98M · Q2 2026
- Remedium Capital Partners, LLC 586.69K sh · $77.87M · Q2 2026
- Soros Fund Management 564.50K sh · $74.93M · Q2 2026
More on DRIEHAUS CAPITAL MANAGEMENT LLC
FAQ
How long has DRIEHAUS CAPITAL MANAGEMENT LLC held APGE?
DRIEHAUS CAPITAL MANAGEMENT LLC has disclosed APGE holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is DRIEHAUS CAPITAL MANAGEMENT LLC's current position in APGE?
As of Q2 2026, DRIEHAUS CAPITAL MANAGEMENT LLC holds 1.74M shares of APGE (APOGEE THERAPEUTICS INC), valued at $230.96M, representing 1.34% of its reported portfolio and ranking #8.
Has DRIEHAUS CAPITAL MANAGEMENT LLC been buying or selling APGE?
In the latest 13F filing (Q2 2026), DRIEHAUS CAPITAL MANAGEMENT LLC reduced its position in APGE. The position peaked in Q2 2026 at 1.74M shares.
Which other funds hold APGE?
Other major institutional holders of APGE include Venrock Adviser, LLC, HBK INVESTMENTS L P, GLAZER CAPITAL, LLC, among 59 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.